Wellington Management Group
TSHA icon

Wellington Management Group’s Taysha Gene Therapies TSHA Stock Holding History

Wellington Management Group’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.8M Sell
626,361
-84,874
-12% -$395K ﹤0.01% 1500
2025
Q4 		$3.91M Buy
711,235
+143,229
+25% +$696K ﹤0.01% 1454
2025
Q3 		$1.86M Sell
568,006
-67,962
-11% -$192K ﹤0.01% 1651
2025
Q2 		$1.47M Buy
635,968
+10,770
+2% +$23.4K ﹤0.01% 1648
2025
Q1 		$869K Buy
625,198
+39,604
+7% +$66.2K ﹤0.01% 1731
2024
Q4 		$1.01M Buy
585,594
+122,402
+26% +$254K ﹤0.01% 1718
2024
Q3 		$931K Buy
+463,192
New +$1.02M ﹤0.01% 1724
2020
Q4 		– Sell
-16,889
Closed -$378K – 2010
2020
Q3 		$378K Buy
+16,889
New +$397K ﹤0.01% 1766

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wellington Management Group's TSHA Position: Q1 2026 in Review

Wellington Management Group reduced its Taysha Gene Therapies (TSHA) stake by 12% in Q1 2026, selling an estimated $395K and leaving 626,361 shares worth $2.8M. The position accounts for ﹤0.01% of the portfolio, ranked #1500.

Wellington Management Group first reported a position in TSHA in Q3 2020 and has held it in 8 quarters since. The position peaked at $3.91M in Q4 2025. 191 funds tracked by Wall St. Rank hold TSHA as of Q1 2026.

  • Wellington Management Group held 626,361 shares of Taysha Gene Therapies worth $2.8M as of Q1 2026.
  • Wellington Management Group sold 84,874 Taysha Gene Therapies shares in Q1 2026, an estimated $395K.
  • Taysha Gene Therapies made up ﹤0.01% of Wellington Management Group's portfolio in Q1 2026, its #1500 holding.
  • Wellington Management Group first reported a position in Taysha Gene Therapies in Q3 2020 and has held it in 8 quarters since.
  • Wellington Management Group's Taysha Gene Therapies position peaked at $3.91M in Q4 2025.
  • 191 funds tracked by Wall St. Rank held Taysha Gene Therapies as of Q1 2026.

Based on Wellington Management Group's 13F filing for Q1 2026, filed 15 May 2026.